Q2 2021 CohBar Inc Earnings Call Transcript
God afternoon. My name is Chuck, and I'll be your conference operator today. At this time, I would like to welcome everyone to CohBar's Second Quarter 2021 Financial Results and Clinical Trial Update Conference Call. (Operator Instructions) Please note, this event is being recorded. Now I would like to turn the conference over to Jordyn Tarazi, Director of Investor Relations at CohBar. Please go ahead, ma'am.
Thank you, Chuck, and thank you, everyone, for joining CohBar's Second Quarter 2021 Financial Results and CB4211 Top Line Data Conference Call. Joining me on today's call is Joe Sarret, CohBar's Chief Executive Officer; Ken Cundy, CohBar's Chief Scientific Officer; and Jeff Biunno, CohBar's Chief Financial Officer. CohBar's CB4211 line data and financial results press releases were issued earlier today and may be downloaded from our website at cohbar.com. Joe will begin with an introduction followed by the CB4211 top line data from Ken. Jeff will then provide an overview of the second quarter financial results.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |